Company profile · free preview

Helus Pharma Inc.

HELP · NASDAQ · Healthcare · Updated 11/16/2026

Five-year financials

Fiscal year
Revenue
Net income
Diluted EPS
Operating cash flow
Free cash flow
Cash
Total debt

Financials are being prepared.

Want the story behind these numbers? Ask Osiris anything about Helus Pharma Inc.'s filings — free.

Create free account

Helus Pharma Inc. return on capital (fiscal 2026)

ROIC

—

Return on capital

—

Return on equity

-84.5%

Return on assets

-77.8%

Gross margin

—

Operating margin

—

Net debt / EBITDA

1.10x

Helus Pharma Inc. insider buying and selling

Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.

DateInsiderTypeSharesPrice
2026-09-29Cavers GregPurchase3,000$12.91

SEC filings

No filings stored yet.

Ask anything about Helus Pharma Inc.'s filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

Compare HELP head-to-head

More Healthcare companies